{ Bioequivalence Studies }
DaVita Clinical Research (DCR) is your source for efficient, well-designed bioequivalence studies
When your goal is to prove that one compound works exactly the same as another, talk to DaVita Clinical Research. DCR provides a full range of generic drug development services, and our scientific and regulatory staff have the expertise you need to conduct streamline bioequivalence programs.
Our comprehensive range of services for bioequivalence studies includes:
-
Protocol design and writing
-
Phase I-IIb studies
-
Bioanalysis
-
Statistical pharmacokinetics
-
Draft and final reports
Our large clinical capacity and recruitment capabilities mean faster study start-up and completion. DCR’s team of generic drug development professionals will assist you in getting your bioequivalence study approved and your product ready for market.
